First-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Cancer With Regorafenib Plus Toripalimab

Conditions:   Gastric Cancer;   Gastro-oesophageal Junction Cancer;   Immunotherapy;   Regorafenib;   Toripalimab Intervention:   Drug: Regorafenib Plus Toripalimab Sponsor:   Shanghai Changzheng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials